You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

SULMEPRIM PEDIATRIC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sulmeprim Pediatric patents expire, and when can generic versions of Sulmeprim Pediatric launch?

Sulmeprim Pediatric is a drug marketed by Usl Pharma and is included in one NDA.

The generic ingredient in SULMEPRIM PEDIATRIC is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sulmeprim Pediatric

A generic version of SULMEPRIM PEDIATRIC was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SULMEPRIM PEDIATRIC?
  • What are the global sales for SULMEPRIM PEDIATRIC?
  • What is Average Wholesale Price for SULMEPRIM PEDIATRIC?
Summary for SULMEPRIM PEDIATRIC
Drug patent expirations by year for SULMEPRIM PEDIATRIC
Recent Clinical Trials for SULMEPRIM PEDIATRIC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Roswell Park Cancer InstitutePhase 4
National Cancer Institute (NCI)Phase 4

See all SULMEPRIM PEDIATRIC clinical trials

US Patents and Regulatory Information for SULMEPRIM PEDIATRIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma SULMEPRIM PEDIATRIC sulfamethoxazole; trimethoprim SUSPENSION;ORAL 070064-001 Aug 1, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.